- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05468931
Prostate Stimulation for Sexual Dysfunction
The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.
Study Overview
Status
Intervention / Treatment
Detailed Description
The purpose of the study is to use a device to stimulate the prostate. The goal of this is to help men with sexual dysfunction. Sexual dysfunction can include conditions like delayed ejaculation (e.g.takes more than 21 minutes to climax) and can hopefully assist them in achieving faster time to ejaculation (e.g. closer to the median of 5.4 minutes in a "normal" individual) along with erectile dysfunction (e.g. the inability to achieve and sustain an erection).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Satvir Basran
- Phone Number: 650-723-0948
- Email: sbasran@stanford.edu
Study Locations
-
-
California
-
Stanford, California, United States, 94304
- Recruiting
- Stanford Healthcare, Stanford Hospital
-
Contact:
- Satvir Basran
- Phone Number: 650-723-0948
- Email: sbasran@stanford.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Males >18 years of age suffering from sexual dysfunction
Exclusion Criteria:
- Individuals who have had a prostatectomy - removal of prostate
- Inability to operate the device for any reason
- Females
- Males <18 years of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prostate stimulation device arm
Participants will be asked to use our prostate stimulation device. |
Prostate stimulation device for sexual dysfunction |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in modified International Index of Erectile Dysfunction score
Time Frame: baseline and up to 1 month post-baseline
|
score 0 to 30 with higher score meaning better erectile function |
baseline and up to 1 month post-baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Eisenberg, M.D., Stanford University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 65918
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.